THB Asset Management’s Emergent Biosolutions EBS Stock Holding History

THB Asset Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$594K	Buy	6,634 +46	+0.7%	+$4.22K	0.13%	137
2020 Q3	$680K	Sell	6,588 -3,690	-36%	-$398K	0.19%	127
2020 Q2	$812K	Buy	10,278 +1,583	+18%	+$118K	0.24%	108
2020 Q1	$503K	Hold	8,695	–	–	0.16%	124
2019 Q4	$469K	Hold	8,695	–	–	0.09%	143
2019 Q3	$454K	Sell	8,695 -10	-0.1%	-$466	0.08%	143
2019 Q2	$420K	Hold	8,705	–	–	0.07%	147
2019 Q1	$439K	Buy	+8,705	New	+$513K	0.06%	141

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

THB Asset Management's EBS Position: Q4 2020 in Review

THB Asset Management increased its Emergent Biosolutions (EBS) stake by 0.7% in Q4 2020, buying an estimated $4.22K and bringing the position to 6,634 shares worth $594K. The position accounts for 0.13% of the portfolio, ranked #137.

THB Asset Management first reported a position in EBS in Q1 2019 and has held it in 8 quarters since. The position peaked at $812K in Q2 2020. 353 funds tracked by Wall St. Rank hold EBS as of Q4 2020.

THB Asset Management held 6,634 shares of Emergent Biosolutions worth $594K as of Q4 2020.
THB Asset Management bought 46 Emergent Biosolutions shares in Q4 2020, an estimated $4.22K.
Emergent Biosolutions made up 0.13% of THB Asset Management's portfolio in Q4 2020, its #137 holding.
THB Asset Management first reported a position in Emergent Biosolutions in Q1 2019 and has held it in 8 quarters since.
THB Asset Management's Emergent Biosolutions position peaked at $812K in Q2 2020.
353 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2020.

Based on THB Asset Management's 13F filing for Q4 2020, filed 5 Feb 2021.